bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer

Volume: 52, Issue: 6, Pages: 1085 - 1090
Published: Dec 1, 1998
Abstract
Objectives. Markers predictive of therapeutic response of prostatic tumors to radiotherapy may have major significance in optimizing effective treatment of prostate cancer. Because inherent cellular radioresistance plays a critical role in the failure of radiotherapy, in this study, we investigated whether there is a correlation between the ratio of two apoptosis regulators, bcl-2 (apoptosis suppressor) and bax (apoptosis inducer) in prostatic...
Paper Details
Title
bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer
Published Date
Dec 1, 1998
Journal
Volume
52
Issue
6
Pages
1085 - 1090
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.